1
|
Makhado BP, Oladipo AO, Gumbi NN, De Kock LA, Andraos C, Gulumian M, Nxumalo EN. Unravelling the toxicity of carbon nanomaterials - From cellular interactions to mechanistic understanding. Toxicol In Vitro 2024; 100:105898. [PMID: 39029601 DOI: 10.1016/j.tiv.2024.105898] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2024] [Revised: 07/03/2024] [Accepted: 07/13/2024] [Indexed: 07/21/2024]
Abstract
The application of carbon nanomaterials in diverse fields has substantially increased their demand for commercial usage. Within the earliest decade, the development of functional materials has further increased the significance of this element. Despite the advancements recorded, the potential harmful impacts of embracing carbon nanomaterials for biological applications must be balanced against their advantages. Interestingly, many studies have neglected the intriguing and dynamic cellular interaction of carbon nanomaterials and the mechanistic understanding of their property-driven behaviour, even though common toxicity profiles have been reported. Reiterating the toxicity issue, several researchers conclude that these materials have minimal toxicity and may be safe for contact with biological systems at certain dosages. Here, we aim to provide a report on the significance of some of the properties that influence their toxicity. After that, a description of the implication of nanotoxicology in humans and living systems, revealing piece by piece their exposure routes and possible risks, will be provided. Then, an extensive discussion of the mechanistic puzzle modulating the interface between various human cellular systems and carbon nanomaterials such as carbon nanotubes, carbon dots, graphene, fullerenes, and nanodiamonds will follow. Finally, this review also sheds light on the organization that handles the risk associated with nanomaterials.
Collapse
Affiliation(s)
- Bveledzani P Makhado
- Institute for Nanotechnology and Water Sustainability, College of Science, Engineering, and Technology, University of South Africa, Roodepoort 1710, South Africa
| | - Adewale O Oladipo
- Department of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa, Roodepoort 1710, South Africa
| | - Nozipho N Gumbi
- Institute for Nanotechnology and Water Sustainability, College of Science, Engineering, and Technology, University of South Africa, Roodepoort 1710, South Africa
| | - Lueta A De Kock
- Institute for Nanotechnology and Water Sustainability, College of Science, Engineering, and Technology, University of South Africa, Roodepoort 1710, South Africa
| | - Charlene Andraos
- Water Research Group, Unit for Environmental Sciences and Management, North-West University Potchefstroom, South Africa; National Institute for Occupational Health (NIOH), National Health Laboratory Service (NHLS), Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Mary Gulumian
- Water Research Group, Unit for Environmental Sciences and Management, North-West University Potchefstroom, South Africa
| | - Edward N Nxumalo
- Institute for Nanotechnology and Water Sustainability, College of Science, Engineering, and Technology, University of South Africa, Roodepoort 1710, South Africa.
| |
Collapse
|
2
|
Li YT, Mei KC, Liam-Or R, Wang JTW, Faruqu FN, Zhu S, Wang YL, Lu Y, Al-Jamal KT. Graphene Oxide Nanosheets Toxicity in Mice Is Dependent on Protein Corona Composition and Host Immunity. ACS NANO 2024; 18:22572-22585. [PMID: 39110092 PMCID: PMC11342366 DOI: 10.1021/acsnano.4c08561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/26/2024] [Revised: 07/26/2024] [Accepted: 07/30/2024] [Indexed: 08/21/2024]
Abstract
Two-dimension graphene oxide (GO) nanosheets with high and low serum protein binding profiles (high/low hard-bound protein corona/HChigh/low) are used in this study as model materials and screening tools to investigate the underlying roles of the protein corona on nanomaterial toxicities in vivo. We proposed that the in vivo biocompatibility/nanotoxicity of GO is protein corona-dependent and host immunity-dependent. The hypothesis was tested by injecting HChigh/low GO nanosheets in immunocompetent ICR/CD1 and immunodeficient NOD-scid II2rγnull mice and performed histopathological and hematological evaluation studies on days 1 and 14 post-injection. HClow GO induced more severe acute lung injury compared to HChigh GO in both immunocompetent and immunodeficient mice, with the effect being particularly pronounced in immunocompetent animals. Additionally, HClow GO caused more significant liver injury in both types of mice, with immunodeficient mice being more susceptible to its hepatotoxic effects. Moreover, administration of HClow GO resulted in increased hematological toxicity and elevated levels of serum pro-inflammatory cytokines in immunocompromised and immunocompetent mice, respectively. Correlation studies were conducted to explore the impact of distinct protein corona compositions on resulting toxicities in both immunocompetent and immunodeficient mice. This facilitated the identification of consistent patterns, aligning with those observed in vitro, thus indicating a robust in vitro-in vivo correlation. This research will advance our comprehension of how hard corona proteins interact with immune cells, leading to toxicity, and will facilitate the development of improved immune-modulating nanomaterials for therapeutic purposes.
Collapse
Affiliation(s)
- Yue-ting Li
- School
of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences
& Medicine, King’s College London, Franklin-Wilkins Building, London SE1 9NH, U.K.
- State
Key Laboratory of Functions and Applications of Medicinal Plants,
Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, No. 9, Beijing Road, Yunyan District, Guiyang 550004, China
| | - Kuo-Ching Mei
- School
of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences
& Medicine, King’s College London, Franklin-Wilkins Building, London SE1 9NH, U.K.
- School
of Pharmacy and Pharmaceutical Sciences, State University of New York at Binghamton, 96 Corliss Avenue, Johnson City, New York 13790, United States
| | - Revadee Liam-Or
- School
of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences
& Medicine, King’s College London, Franklin-Wilkins Building, London SE1 9NH, U.K.
- Department
of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong SAR, China
| | - Julie Tzu-Wen Wang
- School
of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences
& Medicine, King’s College London, Franklin-Wilkins Building, London SE1 9NH, U.K.
| | - Farid N. Faruqu
- School
of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences
& Medicine, King’s College London, Franklin-Wilkins Building, London SE1 9NH, U.K.
| | - Shengzhang Zhu
- Qiannan
People’s Hospital, No. 9, Wenfeng Road, Duyun 558000, China
| | - Yong-lin Wang
- State
Key Laboratory of Functions and Applications of Medicinal Plants,
Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, No. 9, Beijing Road, Yunyan District, Guiyang 550004, China
| | - Yuan Lu
- School
of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences
& Medicine, King’s College London, Franklin-Wilkins Building, London SE1 9NH, U.K.
- State
Key Laboratory of Functions and Applications of Medicinal Plants,
Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, No. 9, Beijing Road, Yunyan District, Guiyang 550004, China
| | - Khuloud T. Al-Jamal
- School
of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences
& Medicine, King’s College London, Franklin-Wilkins Building, London SE1 9NH, U.K.
- Department
of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong SAR, China
| |
Collapse
|
3
|
Andrews JPM, Joshi SS, Tzolos E, Syed MB, Cuthbert H, Crica LE, Lozano N, Okwelogu E, Raftis JB, Bruce L, Poland CA, Duffin R, Fokkens PHB, Boere AJF, Leseman DLAC, Megson IL, Whitfield PD, Ziegler K, Tammireddy S, Hadjidemetriou M, Bussy C, Cassee FR, Newby DE, Kostarelos K, Miller MR. First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses. NATURE NANOTECHNOLOGY 2024; 19:705-714. [PMID: 38366225 PMCID: PMC11106005 DOI: 10.1038/s41565-023-01572-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/11/2023] [Accepted: 11/09/2023] [Indexed: 02/18/2024]
Abstract
Graphene oxide nanomaterials are being developed for wide-ranging applications but are associated with potential safety concerns for human health. We conducted a double-blind randomized controlled study to determine how the inhalation of graphene oxide nanosheets affects acute pulmonary and cardiovascular function. Small and ultrasmall graphene oxide nanosheets at a concentration of 200 μg m-3 or filtered air were inhaled for 2 h by 14 young healthy volunteers in repeated visits. Overall, graphene oxide nanosheet exposure was well tolerated with no adverse effects. Heart rate, blood pressure, lung function and inflammatory markers were unaffected irrespective of graphene oxide particle size. Highly enriched blood proteomics analysis revealed very few differential plasma proteins and thrombus formation was mildly increased in an ex vivo model of arterial injury. Overall, acute inhalation of highly purified and thin nanometre-sized graphene oxide nanosheets was not associated with overt detrimental effects in healthy humans. These findings demonstrate the feasibility of carefully controlled human exposures at a clinical setting for risk assessment of graphene oxide, and lay the foundations for investigating the effects of other two-dimensional nanomaterials in humans. Clinicaltrials.gov ref: NCT03659864.
Collapse
Affiliation(s)
- Jack P M Andrews
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
- The Royal Infirmary of Edinburgh, Edinburgh, UK
| | - Shruti S Joshi
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
| | - Evangelos Tzolos
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
| | - Maaz B Syed
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
| | | | - Livia E Crica
- Nanomedicine Lab, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK
- National Graphene Institute, The University of Manchester, Manchester, UK
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
| | - Emmanuel Okwelogu
- Nanomedicine Lab, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK
| | - Jennifer B Raftis
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
| | - Lorraine Bruce
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
| | - Craig A Poland
- Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK
| | - Rodger Duffin
- Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK
| | - Paul H B Fokkens
- National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
| | - A John F Boere
- National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
| | - Daan L A C Leseman
- National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
| | - Ian L Megson
- Division of Biomedical Sciences, University of the Highlands and Islands, Inverness, UK
| | - Phil D Whitfield
- Division of Biomedical Sciences, University of the Highlands and Islands, Inverness, UK
| | - Kerstin Ziegler
- Division of Biomedical Sciences, University of the Highlands and Islands, Inverness, UK
| | - Seshu Tammireddy
- Division of Biomedical Sciences, University of the Highlands and Islands, Inverness, UK
| | - Marilena Hadjidemetriou
- Nanomedicine Lab, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK
| | - Cyrill Bussy
- Nanomedicine Lab, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK
- National Graphene Institute, The University of Manchester, Manchester, UK
- Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, UK
- Thomas Ashton Institute for Risk and Regulatory Research, The University of Manchester, Manchester, UK
| | - Flemming R Cassee
- National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - David E Newby
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
| | - Kostas Kostarelos
- Nanomedicine Lab, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.
- National Graphene Institute, The University of Manchester, Manchester, UK.
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain.
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Pg. Lluís Companys 23, Barcelona, Spain.
| | - Mark R Miller
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
| |
Collapse
|
4
|
D’Avenio G, Daniele C, Grigioni M. Nanostructured Medical Devices: Regulatory Perspective and Current Applications. MATERIALS (BASEL, SWITZERLAND) 2024; 17:1787. [PMID: 38673144 PMCID: PMC11051465 DOI: 10.3390/ma17081787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/30/2024] [Revised: 04/05/2024] [Accepted: 04/09/2024] [Indexed: 04/28/2024]
Abstract
Nanomaterials (NMs) are having a huge impact in several domains, including the fabrication of medical devices (MDs). Hence, nanostructured MDs are becoming quite common; nevertheless, the associated risks must be carefully considered in order to demonstrate safety prior to their immission on the market. The biological effect of NMs requires the consideration of methodological issues since already established methods for, e.g., cytotoxicity can be subject to a loss of accuracy in the presence of certain NMs. The need for oversight of MDs containing NMs is reflected by the European Regulation 2017/745 on MDs, which states that MDs incorporating or consisting of NMs are in class III, at highest risk, unless the NM is encapsulated or bound in such a manner that the potential for its internal exposure is low or negligible (Rule 19). This study addresses the role of NMs in medical devices, highlighting the current applications and considering the regulatory requirements of such products.
Collapse
Affiliation(s)
- Giuseppe D’Avenio
- National Centre for Innovative Technologies in Public Health, Italian National Institute of Health (ISS), 00161 Rome, Italy; (C.D.); (M.G.)
| | | | | |
Collapse
|
5
|
Lin H, Buerki-Thurnherr T, Kaur J, Wick P, Pelin M, Tubaro A, Carniel FC, Tretiach M, Flahaut E, Iglesias D, Vázquez E, Cellot G, Ballerini L, Castagnola V, Benfenati F, Armirotti A, Sallustrau A, Taran F, Keck M, Bussy C, Vranic S, Kostarelos K, Connolly M, Navas JM, Mouchet F, Gauthier L, Baker J, Suarez-Merino B, Kanerva T, Prato M, Fadeel B, Bianco A. Environmental and Health Impacts of Graphene and Other Two-Dimensional Materials: A Graphene Flagship Perspective. ACS NANO 2024; 18:6038-6094. [PMID: 38350010 PMCID: PMC10906101 DOI: 10.1021/acsnano.3c09699] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/06/2023] [Revised: 01/18/2024] [Accepted: 01/22/2024] [Indexed: 02/15/2024]
Abstract
Two-dimensional (2D) materials have attracted tremendous interest ever since the isolation of atomically thin sheets of graphene in 2004 due to the specific and versatile properties of these materials. However, the increasing production and use of 2D materials necessitate a thorough evaluation of the potential impact on human health and the environment. Furthermore, harmonized test protocols are needed with which to assess the safety of 2D materials. The Graphene Flagship project (2013-2023), funded by the European Commission, addressed the identification of the possible hazard of graphene-based materials as well as emerging 2D materials including transition metal dichalcogenides, hexagonal boron nitride, and others. Additionally, so-called green chemistry approaches were explored to achieve the goal of a safe and sustainable production and use of this fascinating family of nanomaterials. The present review provides a compact survey of the findings and the lessons learned in the Graphene Flagship.
Collapse
Affiliation(s)
- Hazel Lin
- CNRS,
UPR3572, Immunology, Immunopathology and Therapeutic Chemistry, ISIS, University of Strasbourg, 67000 Strasbourg, France
| | - Tina Buerki-Thurnherr
- Empa,
Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Jasreen Kaur
- Nanosafety
& Nanomedicine Laboratory, Institute
of Environmental Medicine, Karolinska Institutet, 177 77 Stockholm, Sweden
| | - Peter Wick
- Empa,
Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Marco Pelin
- Department
of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | - Aurelia Tubaro
- Department
of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | | | - Mauro Tretiach
- Department
of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | - Emmanuel Flahaut
- CIRIMAT,
Université de Toulouse, CNRS, INPT,
UPS, 31062 Toulouse CEDEX 9, France
| | - Daniel Iglesias
- Facultad
de Ciencias y Tecnologías Químicas, Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
- Instituto
Regional de Investigación Científica Aplicada (IRICA), Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
| | - Ester Vázquez
- Facultad
de Ciencias y Tecnologías Químicas, Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
- Instituto
Regional de Investigación Científica Aplicada (IRICA), Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
| | - Giada Cellot
- International
School for Advanced Studies (SISSA), 34136 Trieste, Italy
| | - Laura Ballerini
- International
School for Advanced Studies (SISSA), 34136 Trieste, Italy
| | - Valentina Castagnola
- Center
for
Synaptic Neuroscience and Technology, Istituto
Italiano di Tecnologia, 16132 Genova, Italy
- IRCCS
Ospedale Policlinico San Martino, 16132 Genova, Italy
| | - Fabio Benfenati
- Center
for
Synaptic Neuroscience and Technology, Istituto
Italiano di Tecnologia, 16132 Genova, Italy
- IRCCS
Ospedale Policlinico San Martino, 16132 Genova, Italy
| | - Andrea Armirotti
- Analytical
Chemistry Facility, Istituto Italiano di
Tecnologia, 16163 Genoa, Italy
| | - Antoine Sallustrau
- Département
Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SIMoS, Gif-sur-Yvette 91191, France
| | - Frédéric Taran
- Département
Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SIMoS, Gif-sur-Yvette 91191, France
| | - Mathilde Keck
- Département
Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SIMoS, Gif-sur-Yvette 91191, France
| | - Cyrill Bussy
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, University of Manchester,
Manchester Academic Health Science Centre, National Graphene Institute, Manchester M13 9PT, United
Kingdom
| | - Sandra Vranic
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, University of Manchester,
Manchester Academic Health Science Centre, National Graphene Institute, Manchester M13 9PT, United
Kingdom
| | - Kostas Kostarelos
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, University of Manchester,
Manchester Academic Health Science Centre, National Graphene Institute, Manchester M13 9PT, United
Kingdom
| | - Mona Connolly
- Instituto Nacional de Investigación y Tecnología
Agraria
y Alimentaria (INIA), CSIC, Carretera de la Coruña Km 7,5, E-28040 Madrid, Spain
| | - José Maria Navas
- Instituto Nacional de Investigación y Tecnología
Agraria
y Alimentaria (INIA), CSIC, Carretera de la Coruña Km 7,5, E-28040 Madrid, Spain
| | - Florence Mouchet
- Laboratoire
Ecologie Fonctionnelle et Environnement, Université de Toulouse, CNRS, INPT, UPS, 31000 Toulouse, France
| | - Laury Gauthier
- Laboratoire
Ecologie Fonctionnelle et Environnement, Université de Toulouse, CNRS, INPT, UPS, 31000 Toulouse, France
| | - James Baker
- TEMAS Solutions GmbH, 5212 Hausen, Switzerland
| | | | - Tomi Kanerva
- Finnish Institute of Occupational Health, 00250 Helsinki, Finland
| | - Maurizio Prato
- Center
for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), 20014 Donostia-San
Sebastián, Spain
- Ikerbasque, Basque Foundation for Science, 48013 Bilbao, Spain
- Department
of Chemical and Pharmaceutical Sciences, University of Trieste, 34127 Trieste, Italy
| | - Bengt Fadeel
- Nanosafety
& Nanomedicine Laboratory, Institute
of Environmental Medicine, Karolinska Institutet, 177 77 Stockholm, Sweden
| | - Alberto Bianco
- CNRS,
UPR3572, Immunology, Immunopathology and Therapeutic Chemistry, ISIS, University of Strasbourg, 67000 Strasbourg, France
| |
Collapse
|
6
|
Visani de Luna LA, Loret T, He Y, Legnani M, Lin H, Galibert AM, Fordham A, Holme S, Del Rio Castillo AE, Bonaccorso F, Bianco A, Flahaut E, Kostarelos K, Bussy C. Pulmonary Toxicity of Boron Nitride Nanomaterials Is Aspect Ratio Dependent. ACS NANO 2023; 17:24919-24935. [PMID: 38051272 PMCID: PMC10753895 DOI: 10.1021/acsnano.3c06599] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Revised: 11/26/2023] [Accepted: 12/01/2023] [Indexed: 12/07/2023]
Abstract
Boron nitride (BN) nanomaterials have drawn a lot of interest in the material science community. However, extensive research is still needed to thoroughly analyze their safety profiles. Herein, we investigated the pulmonary impact and clearance of two-dimensional hexagonal boron nitride (h-BN) nanosheets and boron nitride nanotubes (BNNTs) in mice. Animals were exposed by single oropharyngeal aspiration to h-BN or BNNTs. On days 1, 7, and 28, bronchoalveolar lavage (BAL) fluids and lungs were collected. On one hand, adverse effects on lungs were evaluated using various approaches (e.g., immune response, histopathology, tissue remodeling, and genotoxicity). On the other hand, material deposition and clearance from the lungs were assessed. Two-dimensional h-BN did not cause any significant immune response or lung damage, although the presence of materials was confirmed by Raman spectroscopy. In addition, the low aspect ratio h-BN nanosheets were internalized rapidly by phagocytic cells present in alveoli, resulting in efficient clearance from the lungs. In contrast, high aspect ratio BNNTs caused a strong and long-lasting inflammatory response, characterized by sustained inflammation up to 28 days after exposure and the activation of both innate and adaptive immunity. Moreover, the presence of granulomatous structures and an indication of ongoing fibrosis as well as DNA damage in the lung parenchyma were evidenced with these materials. Concurrently, BNNTs were identified in lung sections for up to 28 days, suggesting long-term biopersistence, as previously demonstrated for other high aspect ratio nanomaterials with poor lung clearance such as multiwalled carbon nanotubes (MWCNTs). Overall, we reveal the safer toxicological profile of BN-based two-dimensional nanosheets in comparison to their nanotube counterparts. We also report strong similarities between BNNTs and MWCNTs in lung response, emphasizing their high aspect ratio as a major driver of their toxicity.
Collapse
Affiliation(s)
- Luis Augusto Visani de Luna
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Lydia
Becker Institute of Immunology and Inflammation, Faculty of Biology,
Medicine and Health, The University of Manchester,
Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
| | - Thomas Loret
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Lydia
Becker Institute of Immunology and Inflammation, Faculty of Biology,
Medicine and Health, The University of Manchester,
Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
| | - Yilin He
- CNRS,
Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University
of Strasbourg, ISIS, 67000 Strasbourg, France
| | - Morgan Legnani
- CIRIMAT,
Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université
de Toulouse, 118 Route de Narbonne, 31062 Toulouse cedex 9, France
| | - Hazel Lin
- CNRS,
Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University
of Strasbourg, ISIS, 67000 Strasbourg, France
| | - Anne Marie Galibert
- CIRIMAT,
Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université
de Toulouse, 118 Route de Narbonne, 31062 Toulouse cedex 9, France
| | - Alexander Fordham
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Lydia
Becker Institute of Immunology and Inflammation, Faculty of Biology,
Medicine and Health, The University of Manchester,
Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
| | - Sonja Holme
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Lydia
Becker Institute of Immunology and Inflammation, Faculty of Biology,
Medicine and Health, The University of Manchester,
Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
| | | | - Francesco Bonaccorso
- BeDimensional
S.p.A., Lungo Torrente
Secca 30r, 16163 Genoa, Italy
- Istituto
Italiano di Tecnologia, Graphene Laboratories, Via Morego 30, 16163 Genoa, Italy
| | - Alberto Bianco
- CNRS,
Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University
of Strasbourg, ISIS, 67000 Strasbourg, France
| | - Emmanuel Flahaut
- CIRIMAT,
Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université
de Toulouse, 118 Route de Narbonne, 31062 Toulouse cedex 9, France
| | - Kostas Kostarelos
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Catalan
Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST,, Campus UAB, Bellaterra, 08193 Barcelona, Spain
| | - Cyrill Bussy
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Lydia
Becker Institute of Immunology and Inflammation, Faculty of Biology,
Medicine and Health, The University of Manchester,
Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
| |
Collapse
|
7
|
Loret T, de Luna LAV, Lucherelli MA, Fordham A, Lozano N, Bianco A, Kostarelos K, Bussy C. Lung Persistence, Biodegradation, and Elimination of Graphene-Based Materials are Predominantly Size-Dependent and Mediated by Alveolar Phagocytes. SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2023; 19:e2301201. [PMID: 37264768 DOI: 10.1002/smll.202301201] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Revised: 04/03/2023] [Indexed: 06/03/2023]
Abstract
Graphene-based materials (GBMs) have promising applications in various sectors, including pulmonary nanomedicine. Nevertheless, the influence of GBM physicochemical characteristics on their fate and impact in lung has not been thoroughly addressed. To fill this gap, the biological response, distribution, and bio-persistence of four different GBMs in mouse lungs up to 28 days after single oropharyngeal aspiration are investigated. None of the GBMs, varying in size (large versus small) and carbon to oxygen ratio as well as thickness (few-layers graphene (FLG) versus thin graphene oxide (GO)), induce a strong pulmonary immune response. However, recruited neutrophils internalize nanosheets better and degrade GBMs faster than macrophages, revealing their crucial role in the elimination of small GBMs. In contrast, large GO sheets induce more damages due to a hindered degradation and long-term persistence in macrophages. Overall, small dimensions appear to be a leading feature in the design of safe GBM pulmonary nanovectors due to an enhanced degradation in phagocytes and a faster clearance from the lungs for small GBMs. Thickness also plays an important role, since decreased material loading in alveolar phagocytes and faster elimination are found for FLGs compared to thinner GOs. These results are important for designing safer-by-design GBMs for biomedical application.
Collapse
Affiliation(s)
- Thomas Loret
- Nanomedicine Lab 2.0, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
| | - Luis Augusto Visani de Luna
- Nanomedicine Lab 2.0, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
| | - Matteo Andrea Lucherelli
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, Strasbourg, 67000, France
| | - Alexander Fordham
- Nanomedicine Lab 2.0, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, Barcelona, 08193, Spain
| | - Alberto Bianco
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, Strasbourg, 67000, France
| | - Kostas Kostarelos
- Nanomedicine Lab 2.0, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, Barcelona, 08193, Spain
| | - Cyrill Bussy
- Nanomedicine Lab 2.0, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
| |
Collapse
|
8
|
Czarniewska E, Sielicki K, Maślana K, Mijowska E. In vivo study on borophene nanoflakes interaction with Tenebrio molitor beetle: viability of hemocytes and short-term immunity effect. Sci Rep 2023; 13:11823. [PMID: 37479709 PMCID: PMC10361989 DOI: 10.1038/s41598-023-38595-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2023] [Accepted: 07/11/2023] [Indexed: 07/23/2023] Open
Abstract
The family of graphene-based materials welcomed a new member, borophene, in 2014. Research on synthesis routes and experimental study on physicochemical and biological (especially in vivo) properties still is strongly desired in order to evaluate its practical potential as a drug delivery-system. The effect of two-dimensional borophene nanoflakes on cells, systems and the entire animal organism has not been studied so far. Therefore, we investigated in vivo its biocompatibility with hemocytes in the Tenebrio molitor as a model organism. Short-term studies demonstrated that borophene nanoflakes at doses of 0.5, 1 or 2 µg of nanoflakes per insect did not induce hemocytotoxicity. Hemocytes exposed to nanoflakes showed morphology, adhesiveness and ability to form filopodia as in the control hemocytes. A detailed study indicates that borophene nanoflakes do not: (i) generate intracellular reactive oxygen species in hemocytes, (ii) affect the mitochondrial membrane potential and (iii) interfere with phagocytosis. Therefore, this contribution presents new in vivo insights into the group of two-dimensional materials which are one of the most promising materials for biomedical applications owing to their special structure and unique properties. However, long-term studies in insects and other animals are still necessary to confirm that borophene is biocompatible and biologically safe.
Collapse
Affiliation(s)
- Elżbieta Czarniewska
- Department of Animal Physiology and Developmental Biology, Institute of Experimental Biology, Faculty of Biology, Adam Mickiewicz University in Poznań, Uniwersytetu Poznańskiego Str. 6, 61-614, Poznan, Poland.
| | - Krzysztof Sielicki
- Faculty of Chemical Technology and Engineering, Nanomaterials Physicochemistry Department, West Pomeranian University of Technology, Szczecin, Piastow Ave. 42, 71-065, Szczecin, Poland
| | - Klaudia Maślana
- Faculty of Chemical Technology and Engineering, Nanomaterials Physicochemistry Department, West Pomeranian University of Technology, Szczecin, Piastow Ave. 42, 71-065, Szczecin, Poland
| | - Ewa Mijowska
- Faculty of Chemical Technology and Engineering, Nanomaterials Physicochemistry Department, West Pomeranian University of Technology, Szczecin, Piastow Ave. 42, 71-065, Szczecin, Poland.
| |
Collapse
|
9
|
Zhou X, Jin W, Ma J. Lung inflammation perturbation by engineered nanoparticles. Front Bioeng Biotechnol 2023; 11:1199230. [PMID: 37304133 PMCID: PMC10248179 DOI: 10.3389/fbioe.2023.1199230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2023] [Accepted: 05/09/2023] [Indexed: 06/13/2023] Open
Abstract
In recent years, the unique and diverse physicochemical properties of nanoparticles have brought about their wide use in many fields; however, it is necessary to better understand the possible human health risks caused by their release in the environment. Although the adverse health effects of nanoparticles have been proposed and are still being clarified, their effects on lung health have not been fully studied. In this review, we focus on the latest research progress on the pulmonary toxic effects of nanoparticles, and we summarized their disturbance of the pulmonary inflammatory response. First, the activation of lung inflammation by nanoparticles was reviewed. Second, we discussed how further exposure to nanoparticles aggravated the ongoing lung inflammation. Third, we summarized the inhibition of the ongoing lung inflammation by nanoparticles loaded with anti-inflammatory drugs. Forth, we introduced how the physicochemical properties of nanoparticles affect the related pulmonary inflammatory disturbance. Finally, we discussed the main gaps in current research and the challenges and countermeasures in future research.
Collapse
Affiliation(s)
| | | | - Jingjun Ma
- College of Science and Technology, Hebei Agricultural University, Cangzhou, China
| |
Collapse
|
10
|
Wang T, Russo DP, Bitounis D, Demokritou P, Jia X, Huang H, Zhu H. Integrating structure annotation and machine learning approaches to develop graphene toxicity models. CARBON 2023; 204:484-494. [PMID: 36845527 PMCID: PMC9957041 DOI: 10.1016/j.carbon.2022.12.065] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Modern nanotechnology provides efficient and cost-effective nanomaterials (NMs). The increasing usage of NMs arises great concerns regarding nanotoxicity in humans. Traditional animal testing of nanotoxicity is expensive and time-consuming. Modeling studies using machine learning (ML) approaches are promising alternatives to direct evaluation of nanotoxicity based on nanostructure features. However, NMs, including two-dimensional nanomaterials (2DNMs) such as graphenes, have complex structures making them difficult to annotate and quantify the nanostructures for modeling purposes. To address this issue, we constructed a virtual graphenes library using nanostructure annotation techniques. The irregular graphene structures were generated by modifying virtual nanosheets. The nanostructures were digitalized from the annotated graphenes. Based on the annotated nanostructures, geometrical nanodescriptors were computed using Delaunay tessellation approach for ML modeling. The partial least square regression (PLSR) models for the graphenes were built and validated using a leave-one-out cross-validation (LOOCV) procedure. The resulted models showed good predictivity in four toxicity-related endpoints with the coefficient of determination (R2) ranging from 0.558 to 0.822. This study provides a novel nanostructure annotation strategy that can be applied to generate high-quality nanodescriptors for ML model developments, which can be widely applied to nanoinformatics studies of graphenes and other NMs.
Collapse
Affiliation(s)
- Tong Wang
- Department of Chemistry and Biochemistry, Rowan University, Glassboro, NJ 08028, USA
| | - Daniel P. Russo
- Department of Chemistry and Biochemistry, Rowan University, Glassboro, NJ 08028, USA
| | - Dimitrios Bitounis
- Center for Nanotechnology and Nanotoxicology, Department of Environmental Health, T.H. Chan School of Public Health, Harvard University, 655 Huntington Ave, Boston, MA 02115, USA
- Nanoscience and Advanced Materials Center, Environmental Occupational Health Sciences Institute, School of Public Health, Rutgers University, Piscataway, New Jersey 08854, USA
| | - Philip Demokritou
- Center for Nanotechnology and Nanotoxicology, Department of Environmental Health, T.H. Chan School of Public Health, Harvard University, 655 Huntington Ave, Boston, MA 02115, USA
- Nanoscience and Advanced Materials Center, Environmental Occupational Health Sciences Institute, School of Public Health, Rutgers University, Piscataway, New Jersey 08854, USA
| | - Xuelian Jia
- Department of Chemistry and Biochemistry, Rowan University, Glassboro, NJ 08028, USA
| | - Heng Huang
- Department of Electrical and Computer Engineering, Department of Biomedical Informatics, University of Pittsburgh, 5607 Baum Boulevard, Pittsburgh, Pennsylvania, USA
| | - Hao Zhu
- Department of Chemistry and Biochemistry, Rowan University, Glassboro, NJ 08028, USA
| |
Collapse
|
11
|
Graphene quantum dots disturbed the energy homeostasis by influencing lipid metabolism of macrophages. Toxicology 2023; 484:153389. [PMID: 36481571 DOI: 10.1016/j.tox.2022.153389] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2022] [Revised: 11/26/2022] [Accepted: 12/03/2022] [Indexed: 12/12/2022]
Abstract
To investigate the potential factors of graphene quantum dots (GQDs), the assessment impact on the innate immune system is one of the most important. As the innate immune cell, macrophages possess phagocytosis activity and affect immunomodulation. Higher oxygen consumption rates (OCR) are used to gain insight into GQDs' effects on macrophages. Metabolomics profiling also revealed that GQDs exposure provoked an increase in phosphoglycerides, sphingolipids, and oxidized lipids in macrophages. The molecular pathways disrupted by GQDs were associated with lipid and energy metabolisms. Metabolite flux analysis was used to evaluate changes in the lipid metabolism of macrophages exposed to 100 µg mL-1 GQDs for 24 and 48 h. A combination of 13C-flux analysis and metabolomics revealed the regulation of lipid biosynthesis influenced the balance of energy metabolism. Integrated proteomics and metabolomics analyses showed that nicotinic acid adenine dinucleotide and coenzyme Q10 were significantly increased under GQDs treatment, alongside upregulated protein activity (e.g., Cox5b and Cd36). The experimental evidences were expected to be provided in this study to reveal the potential harmful effect from exposure to GQDs.
Collapse
|